Per protocol analysis
When analysis was performed on the basis of treatment randomised being
the same as that received (i.e. per-protocol), the difference in
delivery costs reduced to just $87 more using STan, and the difference
in maternal readmission rates and costs were also reduced. However, the
magnitude of the cost difference associated with neonatal admissions was
enlarged, such that difference in overall total costs increased to
$2,824 per dyad, favouring CTG+STan. (Table 4).